{"id":522864,"date":"2021-08-04T07:08:08","date_gmt":"2021-08-04T11:08:08","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\/"},"modified":"2021-08-04T07:08:08","modified_gmt":"2021-08-04T11:08:08","slug":"clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\/","title":{"rendered":"Clearside Biomedical to Participate in Two Upcoming Investor Conferences in August 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">ALPHARETTA, Ga., Aug.  04, 2021  (GLOBE NEWSWIRE) &#8212; Clearside Biomedical, Inc.\u00a0(NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that George Lasezkay, Pharm.D., J.D., President and Chief Executive Officer, and Thomas A. Ciulla, M.D., MBA, Chief Medical Officer and Chief Development Officer, will participate in two upcoming investor conferences in August 2021:<\/p>\n<p align=\"justify\">\n        <strong>Wedbush PacGrow Healthcare Virtual Conference<\/strong><br \/>\n        <br \/>Panel Discussion: <em>Goldeneye<\/em><br \/>Wednesday, August 11, 2021 at 9:45 am ET<\/p>\n<p align=\"justify\">\n        <strong>H.C. Wainwright Ophthalmology Virtual Conference<\/strong><br \/>\n        <br \/>Panel Discussion: <em>Vision Repair Beyond Traditional Anti-VEGF Therapy<\/em><br \/>Tuesday, August 17, 2021 at 12:00 pm ET<br \/>Corporate Presentation available Tuesday, August 17, 2021 at 7:00 am ET<\/p>\n<p align=\"justify\">A link to the live and archived webcasts may be accessed on the Clearside website under the Investors section: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8axCPMRfzqmvH11HhAKRALvgTZTZ_VGDBq9YlOsJCvhV_s92gkZxKKKxwXRcZ63wkOBL70venqnyKKJKz8lWgnYiHSWv1eCurP415Il1KlapY2uFCBky-kYsjyDZ2rdZYDTlAR3ppxnUOa_tP2CB5Q==\" rel=\"nofollow noopener\" target=\"_blank\">Events and Presentations<\/a>. An archive of the webcast will be available for three months.<\/p>\n<p align=\"justify\">\n        <strong>About Clearside Biomedical<\/strong>\n      <\/p>\n<p align=\"justify\">Clearside Biomedical, Inc. is a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases. Clearside\u2019s proprietary SCS Microinjector<sup>\u00ae<\/sup> targets the suprachoroidal space (SCS<sup>\u00ae<\/sup>) and offers unique access to the macula, retina and choroid where sight-threatening disease often occurs. The Company\u2019s SCS injection platform is an inherently flexible, in-office, non-surgical procedure, intended to provide targeted delivery to the site of disease and to work with both established and new formulations of medications. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fFe_sAIsfQYOVR_F-kGGvtxqwA_zlwxtnoD8VNTjsPWhbr-0TIKlmvmiDUQvjHhrfeX-ZuPuVlAum_BfWfsbgONnmckSJQNiesGK8DC54Co=\" rel=\"nofollow noopener\" target=\"_blank\">www.clearsidebio.com<\/a>.<\/p>\n<p>\n        <strong>Investor and Media Contacts:<\/strong><\/p>\n<p>Jenny Kobin <br \/>Remy Bernarda <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1tAC0mIHn5jUhRfNNUrt0TUzlp7AlotXp8ne-0dmZfz6fJveYHQzUNZnyCljZGbxE0WyF1rifJHgjeyqbZ-_IBlfXoG0RG6bZYb4AqXQfVU=\" rel=\"nofollow noopener\" target=\"_blank\">ir@clearsidebio.com<\/a><br \/>(678) 430-8206<\/p>\n<p>Source: Clearside Biomedical, Inc.<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMjM3NCM0MzQwMjYwIzIwMTExNjI=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/b5951c58-4038-4340-a864-b14aca255fb5\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ALPHARETTA, Ga., Aug. 04, 2021 (GLOBE NEWSWIRE) &#8212; Clearside Biomedical, Inc.\u00a0(NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that George Lasezkay, Pharm.D., J.D., President and Chief Executive Officer, and Thomas A. Ciulla, M.D., MBA, Chief Medical Officer and Chief Development Officer, will participate in two upcoming investor conferences in August 2021: Wedbush PacGrow Healthcare Virtual Conference Panel Discussion: GoldeneyeWednesday, August 11, 2021 at 9:45 am ET H.C. Wainwright Ophthalmology Virtual Conference Panel Discussion: Vision Repair Beyond Traditional Anti-VEGF TherapyTuesday, August 17, 2021 at 12:00 pm ETCorporate Presentation available Tuesday, August 17, 2021 at 7:00 am ET A link to the live and &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Clearside Biomedical to Participate in Two Upcoming Investor Conferences in August 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-522864","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Clearside Biomedical to Participate in Two Upcoming Investor Conferences in August 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clearside Biomedical to Participate in Two Upcoming Investor Conferences in August 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ALPHARETTA, Ga., Aug. 04, 2021 (GLOBE NEWSWIRE) &#8212; Clearside Biomedical, Inc.\u00a0(NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that George Lasezkay, Pharm.D., J.D., President and Chief Executive Officer, and Thomas A. Ciulla, M.D., MBA, Chief Medical Officer and Chief Development Officer, will participate in two upcoming investor conferences in August 2021: Wedbush PacGrow Healthcare Virtual Conference Panel Discussion: GoldeneyeWednesday, August 11, 2021 at 9:45 am ET H.C. Wainwright Ophthalmology Virtual Conference Panel Discussion: Vision Repair Beyond Traditional Anti-VEGF TherapyTuesday, August 17, 2021 at 12:00 pm ETCorporate Presentation available Tuesday, August 17, 2021 at 7:00 am ET A link to the live and &hellip; Continue reading &quot;Clearside Biomedical to Participate in Two Upcoming Investor Conferences in August 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-04T11:08:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMjM3NCM0MzQwMjYwIzIwMTExNjI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Clearside Biomedical to Participate in Two Upcoming Investor Conferences in August 2021\",\"datePublished\":\"2021-08-04T11:08:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\\\/\"},\"wordCount\":267,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMjM3NCM0MzQwMjYwIzIwMTExNjI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\\\/\",\"name\":\"Clearside Biomedical to Participate in Two Upcoming Investor Conferences in August 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMjM3NCM0MzQwMjYwIzIwMTExNjI=\",\"datePublished\":\"2021-08-04T11:08:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMjM3NCM0MzQwMjYwIzIwMTExNjI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMjM3NCM0MzQwMjYwIzIwMTExNjI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clearside Biomedical to Participate in Two Upcoming Investor Conferences in August 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clearside Biomedical to Participate in Two Upcoming Investor Conferences in August 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\/","og_locale":"en_US","og_type":"article","og_title":"Clearside Biomedical to Participate in Two Upcoming Investor Conferences in August 2021 - Market Newsdesk","og_description":"ALPHARETTA, Ga., Aug. 04, 2021 (GLOBE NEWSWIRE) &#8212; Clearside Biomedical, Inc.\u00a0(NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that George Lasezkay, Pharm.D., J.D., President and Chief Executive Officer, and Thomas A. Ciulla, M.D., MBA, Chief Medical Officer and Chief Development Officer, will participate in two upcoming investor conferences in August 2021: Wedbush PacGrow Healthcare Virtual Conference Panel Discussion: GoldeneyeWednesday, August 11, 2021 at 9:45 am ET H.C. Wainwright Ophthalmology Virtual Conference Panel Discussion: Vision Repair Beyond Traditional Anti-VEGF TherapyTuesday, August 17, 2021 at 12:00 pm ETCorporate Presentation available Tuesday, August 17, 2021 at 7:00 am ET A link to the live and &hellip; Continue reading \"Clearside Biomedical to Participate in Two Upcoming Investor Conferences in August 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-04T11:08:08+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMjM3NCM0MzQwMjYwIzIwMTExNjI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Clearside Biomedical to Participate in Two Upcoming Investor Conferences in August 2021","datePublished":"2021-08-04T11:08:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\/"},"wordCount":267,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMjM3NCM0MzQwMjYwIzIwMTExNjI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\/","name":"Clearside Biomedical to Participate in Two Upcoming Investor Conferences in August 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMjM3NCM0MzQwMjYwIzIwMTExNjI=","datePublished":"2021-08-04T11:08:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMjM3NCM0MzQwMjYwIzIwMTExNjI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMjM3NCM0MzQwMjYwIzIwMTExNjI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-august-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Clearside Biomedical to Participate in Two Upcoming Investor Conferences in August 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/522864","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=522864"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/522864\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=522864"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=522864"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=522864"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}